Clinical Trial Update: Study of Antibody for Methamphetamine Outpatient Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of an antibody for methamphetamine dependence has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Abuse
• Methamphetamine Dependence

Drugs mentioned

• InterveXion Therapeutics antibody (unnamed in snippet)

Snippet

Sponsor: InterveXion Therapeutics, LLC | Conditions: Methamphetamine-dependence, Methamphetamine Abuse | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-03-10